ANJI PHARMA

Serial Number 88446828
602

Registration Progress

Application Filed
May 26, 2019
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

ANJI PHARMA

Basic Information

Serial Number
88446828
Filing Date
May 26, 2019
Abandonment Date
August 24, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Sep 3, 2020
Classes
042

Rights Holder

Anji Pharmaceuticals Inc.

03
Address
Hibiscus Way, 802 West Bay Road
P.O. Box 31119 Grand Pavilion
Grand Cayman KY1-1205
KY

Ownership History

Anji Pharmaceuticals Inc.

Original Applicant
03
Grand Cayman KY

Legal Representation

Attorney
Jenevieve Maerker, Esq.

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Sep 3, 2020 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Sep 3, 2020 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jul 22, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 22, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 22, 2020 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jul 22, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 21, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 21, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Feb 21, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Feb 11, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 10, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 10, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 15, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 15, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 15, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 11, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 29, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Drug discovery services; Pharmaceutical research and development; Pharmaceutical drug development services
First Use Anywhere: Feb 15, 2018
First Use in Commerce: Feb 15, 2018

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"